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To expect that all patients undergoing major surgery can
have unﬂawed outcomes is not realistic. Surgery is per-
formed by humans on humans and always will have
complications such as nosocomial infections. Despite the
progress in surgery and anaesthesia, the risk of developing
nosocomial infections remains a real threat as more
patients of greater age and with more co-morbidity are to
be operated on [1].
Ventilator-associated pneumonia (VAP) is the most
frequent intensive care unit (ICU) acquired infection
among patients receiving mechanical ventilation (MV)
[2, 3]. Analysis of the impact of VAP on health care
revealed it to be responsible for a signiﬁcant increase in
mortality, morbidity, and lengths of MV and ICU stay
[3–7]. Needless to say, prevention of VAP is essential.
This issue of Intensive Care Medicine contains a report
by Hortal et al. of a prospective study conducted to
identify potentially modiﬁable risk factors for VAP in
patients undergoing cardiac surgery amenable for inter-
vention [8]. As a secondary objective they tried to derive
an easy-to-calculate risk score from their multivariate
analysis. They found a cumulative incidence of VAP of
5.7%. In the sub-group of patients needing MV longer
than 48 h VAP incidence was 45.9%. Overall, the main
pathogens causing VAP were Enterobacteriaceae
(32.8%), Pseudomonas aeruginosa (28.6%), and Staphy-
lococcus aureus (27.1%). Importantly, 65.8% of these
S. aureus infections were MRSA. Obviously patients with
VAP had a longer ICU stay (25.5 days vs. 3 days).
Overall in-hospital mortality in the study population was
6.9%. However, 90 patients were excluded as a result of
intra-operative or early post-operative (48 h) death,
leading to an overall mortality of 11.2%.
Risk factors found were: age [70, blood transfusion,
days of MV, cardiopulmonary bypass time, reintubation,
emergent surgery, intraoperative inotropic support, and
previous cardiac surgery.
The colonization of the host by potentially pathogenic
micro-organisms is a prerequisite for the development of
nosocomial infections. Whether an infection develops is
the result of the dynamic interactions that take place
between a host, a potential pathogen, and the environ-
ment. It occurs when host defense strategies are
successfully evaded by micro-organisms and results in
deleterious changes in the host. Multiple risk factors
contribute to microbial pathogenicity. Hortal et al.
suggest that most risk factors are not amenable to inter-
vention. The risk factors found are not surprising in a
surgical population at higher risk of developing infections
because patients are older and with more comorbidity.
But what can, or must, be done to prevent the develop-
ment of VAP (in patients undergoing cardiac surgery)?
Excellent surgical technique still remains one of the most
important factors in the prevention of nosocomial infec-
tions. For instance, inadequate hemostasis can lead to
hypovolemia resulting in an increased need for blood
transfusion, inotropic support, duration of surgery, or
even possible re-operation [9]. But ﬁrst, prevention
should be focused on optimizing host defenses.
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surgery should be regarded as an opportunity to reduce
nosocomial infection risk and improve the patient’s gen-
eral health. In patients undergoing CABG surgery a
preoperative inspiratory muscle-training program reduced
the incidence of pneumonia by 13% [10]. After surgery,
malnutrition is associated with increased mortality,
increased length of hospital stay, and postoperative
complications, including increased risk of infection [10].
Early recognition of malnourished patients is essential for
prevention of postoperative complications. Careful pre-
operative nutritional assessment is therefore important in
order to make an early diagnosis [11, 12]. This can be
performed by a validated, easy-to-use hospital screening
tool such as the short nutritional assessment questionnaire
(SNAQ) [12]. Experimental studies have shown that
nutritional support containing L-arginine, omega-3 poly-
unsaturated fatty acids, and nucleotides improves
preoperative host defenses and subsequently reduces
postoperative infections. So far only one level I trial has
suggested that intake of immune-enhancing nutritional
supplement for a minimum of ﬁve days preoperatively
can improve outcome in high-risk patients undergoing
elective cardiac surgery [13].
Thereafter, the microbiological burden should be con-
trolled. The pathogenesis of pneumonia, including VAP,
involves aspiration of bacteria from the oropharynx into
the lung, especially during MV. Several systematic
reviews and guidelines now available have made recom-
mendations including: try to minimize the duration of
intubations as much as possible, for instance by imple-
menting weaning protocols or interrupted sedation
schedules; try to avoid reintubation, for instance by non-
invasive-ventilation; try to avoid a supine patient position,
especially when a patient receives enteral feeding; use
closed ventilator circuits; try to reduce aspiration of
oropharyngeal secretions, for instance by continuous
aspiration of subglottic secretions; and minimize the risk
of cross-transmission of pathogens in the ICU by
enforcing optimal hand hygiene and maintaining adequate
stafﬁng levels [4, 14–17].
Several studies have identiﬁed the pivotal role of
oropharyngeal colonization in the pathogenesis of VAP.
Reductions in the incidence of VAP have been
achieved by use of prophylactic antibiotic regimens
given intravenously, given topically in the oropharynx,
or given as part of selective decontamination of the
digestive tract (SDD) or selective oropharyngeal
decontamination (SOD). A recent trial comparing SDD
and SOD found similar effects on survival [18].
Therefore, the SOD regimen seems preferable to the
SDD regimen because it does not include widespread
systemic prophylaxis with cephalosporins and involves
a lower volume of topical antibiotics, thus minimizing
the risk of selection for and development of antibiotic
resistance in the long term. Selection of antibiotic
resistance remains the major disadvantage of these
strategies, however, limiting its applicability in settings
with high levels of antibiotic resistance including set-
tings in which Hortal et al. performed their study [19,
20]. MRSA was found in almost 50% of all S. aureus
infections. Therefore, oropharyngeal decontamination
with antiseptic agents, for example chlorhexidine glu-
conate (CHX), seems to be an important alternative.
This is an inexpensive and effective solution and is
virtually devoid of adverse effects. Results from long-
term clinical studies have indicated no adverse altera-
tions in microbial resistance. Two recent trials found
important absolute risk reductions of VAP (6.5 and 8%)
in patients treated with CHX [21, 22].
To identify a population at high-risk of pneumonia
Hortal et al. try to develop a ‘‘day-zero score’’ with the
variables available before surgery. In this way high-risk
patients can be identiﬁed and targeted preventive mea-
sures can be started in a cost-effective manner. The score
would accurately identify 93% of patients who will
develop pneumonia, with a speciﬁcity of 40%. The score
is of limited use because it is based on a small numbers of
patients. The authors state that further studies, especially
with a large sample size, are needed to validate this score.
A ‘‘day-3 score’’ was developed to identify patients at
higher risk of developing pneumonia among those who
remained ventilated for more than 48 h. These patients
could be candidates for antimicrobial preventive mea-
sures. The only risk factor found was age[70 years. As
high levels of antibiotic-resistant bacteria were found,
antimicrobial preventive measures like SDD or SOD
should, obviously, not be used. In this setting, CHX seems
to be an important alternative [21, 22]. But as this method
is easy-to-use, inexpensive, and with virtually no adverse
effects, it can be used in all patients undergoing cardiac
surgery.
vVAP still remains a frequent ICU-acquired infection
responsible for a signiﬁcant increase in morbidity and
mortality. Hortal et al. deﬁne a number of risk factors
and give a start by suggesting a risk score for medical
decision-making on duration of intensive care and
mechanical ventilation. In contrast with the suggestion
of Hortal et al., we take the position that risk factors
are amenable to intervention. For patients undergoing
major surgery the situation is similar to that in sports—
winning begins with optimal preparation followed by a
good defense.
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